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Abstract
Author Manuscript

Background—Exposure to traffic pollution has been linked to numerous adverse health
endpoints. Despite this, limited data examining traffic exposures during realistic commutes and
acute response exists. Objectives: We conducted the Atlanta Commuters Exposures (ACE-1)
Study, an extensive panel-based exposure and health study, to measure chemically-resolved invehicle exposures and corresponding changes in acute oxidative stress, lipid peroxidation,
pulmonary and systemic inflammation and autonomic response.
Methods—We recruited 42 adults (21 with and 21 without asthma) to conduct two 2-h scripted
highway commutes during morning rush hour in the metropolitan Atlanta area. A suite of invehicle particulate components were measured in the subjects’ private vehicles. Biomarker
measurements were conducted before, during, and immediately after the commutes and in 3
hourly intervals after commutes.
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Results—At measurement time points within 3 h after the commute, we observed mild to
pronounced elevations relative to baseline in exhaled nitric oxide, C-reactive-protein, and exhaled
malondialdehyde, indicative of pulmonary and systemic inflammation and oxidative stress
initiation, as well as decreases relative to baseline levels in the time-domain heart-rate variability
parameters, SDNN and rMSSD, indicative of autonomic dysfunction. We did not observe any
detectable changes in lung function measurements (FEV1, FVC), the frequency-domain heart-rate
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variability parameter or other systemic biomarkers of vascular injury. Water soluble organic
carbon was associated with changes in eNO at all post-commute time-points (p < 0.0001).
Conclusions—Our results point to measureable changes in pulmonary and autonomic
biomarkers following a scripted 2-h highway commute.
Keywords
Car commute; Exhaled nitric oxide; Heart rate variability; Asthma

1. Introduction

Author Manuscript

There is considerable evidence from observational and controlled studies linking trafficrelated pollution and adverse health (HEI, 2010). Although the etiology of traffic pollution
health effects is complex and may be mediated via numerous pathways (Brook et al., 2010),
it is possible that biological response to traffic pollution components or mixtures is elicited
following very short-term exposures (Ghio et al., 2003; Peters et al., 2004). Daily
commuters may be especially vulnerable given their proximity and enhanced exposures to
traffic-related pollution, as well as other non-chemical stressors including noise and
psychosocial stress. While time spent daily in traffic may be limited, exposure assessments
measuring in-vehicle pollutant concentrations indicate that even short durations inside
vehicles (~30 min) can contribute substantially to total daily exposures to particulate matter
(PM) (Adams et al., 2001; Boogaard et al., 2009; Rodes et al., 1998; Sioutas et al., 2005;
Zuurbier et al., 2010). Despite this, there is still considerable uncertainty concerning invehicle exposures during typical commuting scenarios and corresponding cardiorespiratory
responses for daily commuters.

Author Manuscript

Panel-based exposure studies afford unique opportunities to investigate the impacts of
commuting on health, given their ability to accurately measure both real world exposures
and health response on an individual level. An important panel study of highway patrolmen
in North Carolina reported associations between in-vehicle PM exposures over 8 h shifts and
acute changes in systemic inflammation biomarkers and cardiac autonomic function
(Riediker et al., 2004). Among the notable findings from this study was that sub-clinical
biological changes in cardiorespiratory response were observed in young, healthy, active
adults following exposures to traffic PM at commonly experienced levels. Subsequent invehicle panel studies have provided additional indication that exposures experienced during
scripted car or bus commutes may be associated with measures of heart rate variability
(Adar et al., 2007; Laumbach et al., 2010; Shields et al., 2013; Wu et al., 2010) and
pulmonary inflammation (Zuurbier et al., 2011).

Author Manuscript

Although suggestive, results from these initial commuter panel studies provide inconsistent
evidence concerning the specific factors most associated with response or specific biological
pathways most associated with exposures. Some of this inconsistency is likely due to the
complexity of the in-vehicle microenvironment, comprising a combination of chemical,
physical and psychosocial stressors. A more complete understanding of in-vehicle exposures
and health for commuters is becoming increasingly necessary, as commuting durations as
well as roadway congestion have steadily increased throughout the U.S. during the last 20
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years. Over 10 million Americans spend greater than two hours each day commuting to and
from their place of work, with 61% of those commuters driving alone (U.S. Census Bureau,
2011 American Community Survey Reports, 2011 Out-of-State and Long Commutes: 2011
Brian McKenzie).
To investigate in-vehicle exposures among daily car commuters and provide additional
insight into the potential health effects of this activity, we conducted two large, panel-based
exposure and health assessment studies in the metropolitan Atlanta area, including adults
with and without asthma. The current analysis presents results from the initial Atlanta
Commuters Exposure (ACE) study, ACE-1, which included measurements collected for
over 80 morning rush hour commutes. We examined the hypothesis that exposures occurring
during rush hour car commuting lead to acute changes in cardiorespiratory response,
consistent with oxidative-stress mediated pathways of injury.

Author Manuscript

2. Methods

Author Manuscript

In-vehicle pollutant exposures and corresponding biomarker measurements were collected
for 21 adults with self-reported asthma and 21 non-asthmatic adults between December
2009 and April 2011. Subjects used their personal vehicles to conduct a scripted commute
lasting approximately 2 h during the morning rush hour period (7–9 AM) in the metropolitan
Atlanta area. Commute routes began and ended at our environmental health laboratory at the
Rollins School of Public Health of Emory University. Routes were similar among commutes
and were designed to include heavily used commuting roadways with both gasoline and
diesel engine vehicles. Trained field technicians accompanied subjects throughout the entire
commute. Each subject conducted two scripted commutes as part of the protocol, with the
exception of 3 subjects who withdrew from the study after conducting a single commute.
The repeat commutes for a given subject were scheduled at varying time intervals from the
initial commute, ranging from 2 weeks to 17 months, with a median between-commute
interval of 4 months.
The driver's side window was alternately opened for 15 min and then closed for 15 min
throughout the commute except during rain or uncomfortably cold temperatures. Subjects
were allowed to use the vehicle's air condition or ventilation system but were asked to use
the outside air setting throughout the commute.
2.1. Exclusion criteria

Author Manuscript

Subjects for this study were recruited largely by word of mouth and flyers posted on the
Emory University and Centers for Disease Control and Prevention (CDC) campuses. To
limit exposure to traffic pollution prior to the study commute, we restricted subjects to those
living within close proximity (within 15 min drive) of our laboratory facility and commute
start point. One subject, who lived approximately 20 miles from our facility, was met by
field staff at their residence and began the commute from that location. Participants were
considered ‘Asthmatics” if they self -reported ever being diagnosed by a health provider of
having asthma. All participants with asthma were instructed to continue normal medication
regimens throughout their participation in the study.
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We excluded individuals who were pregnant; had diabetes; a previous myocardial infarction;
implantable cardioverter-defibrillators or pacemakers; used digoxin or beta blockers for
treatment of hypertension or arrhythmias; or had non-asthma pulmonary disease such as
COPD, emphysema, any type of lung cancer, or a forced expiratory volume in 1 s (FEV1)
less than 70% predicted at baseline. We excluded individuals who smoked. The study was
approved by the Emory Institutional Review Board. Written informed consent was provided
by all participants.
2.2. Biomarker measurements

Author Manuscript

Prior to sampling, each subject was administered a baseline questionnaire assessing factors
related to both exposure and health, including proximity of subject residences to major
roadways, potential exposures to indoor or outdoor pollution events, and recent health status.
Approximately 30 min before each commute, a trained field technician and phlebotomist
met with subjects at our laboratory facilities at Emory University to conduct initial baseline
measurements (~6:30 AM). Biomarker measurements were also conducted during and
immediately following the commute (0 h), as well as at hourly intervals for 3 hours after the
commutes. In between measurements, participants were asked not to leave the surrounding
area of the clinic.

Author Manuscript

The selected biomarker measurements were targeted primarily to assess acute response
consistent with oxidative stress and inflammation pathways. The specific endpoints included
those that have been shown in previous studies to be related to exposure to ambient
particulate or gas-phase pollution (Brook et al., 2010; Ghio et al., 2003; Hertel et al., 2010;
Mills et al., 2007; Park et al., 2010). For the current analysis, we examined lung function,
exhaled nitric oxide (eNO), malondialdehyde (MDA) in exhaled breath condensate (EBC),
C-reactive protein (CRP) and heart rate variability (HRV) parameters. Several additional
circulating biomarkers of systemic inflammation including soluble intercellular adhesion
molecule-1 (sICAM-1), soluble vascular adhesion molecule-1 (sVCAM1), interleukin 1
(IL-1β), interleukin 6 (IL-6), interleukin 8 (IL-8), and tumor necrosis factor alpha (TNF-α)
were analyzed in plasma, which was collected at the pre-commute baseline and 3 h postcommute time points only.

Author Manuscript

The concentration of NO in exhaled breath, an indicator of acute bronchial inflammation
and oxidative stress (Alving and Malinovschi, 2010), was measured first, using the portable
NIOX MINO analyzer (Aerocrine, New Providence, NJ, USA). Participants were asked not
to consume foods with high levels of nitrates (i.e. spinach, beets, radishes, celery, cabbage
and cured meats) the night before the study and throughout the day of the study, in order to
eliminate the effect of nutrition on eNO measurements. They were asked not to eat 30 min
prior to each biomarker measurement session. FEV1 and forced vital capacity (FVC)
measurements were performed with the use of an OHD KoKo spirometer (Occupational
Health Dynamics, Birmingham, AL, USA). Metrics of lung function are presented as
percent of age-, sex-, and race-specific predicted values (Hankinson et al., 1999). EBC was
collected during a tidal breathing protocol with the use of a standardized breath-condensate
collector which was stored at −80 °C prior to sampling (RTube, Austin, T, USA).
Concentrations of MDA in the expired droplets of respiratory tract lining fluid, a marker of
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pulmonary lipid peroxidation in EBC were measured using a high-performance liquid
chromatography (HPLC) technique to assess the progression of airway lipid peroxidation
reactions (Lärstad et al., 2002). We measured CRP in blood obtained from finger prick
samples collected at each of the measurement periods (Cholestech LDX system, Inverness
Medical, Hayward, CA, USA). Blood was drawn by a trained phlebotomist at our clinical
facility from an antecubital vein and immediately centrifuged to separate plasma. The suite
of inflammation biomarkers in plasma were analyzed according to manufacturer's
specifications at the National Health and Environmental Effects Research Laboratory of the
US Environmental Protection Agency (Vascular Injury Panel II assay, Human Proinflammatory II 4-plex assay ultra-sensitive kit, MesoScale Discovery, Gaithersburg, MD).
Blood pressure was measured using the Ambulo 2400 ABPM System (Tiba Medical,
Portland, OR, USA).

Author Manuscript
Author Manuscript

Heart rate and heart rate variability (HRV) were recorded continuously throughout the
commute and during the entire sampling day using a 5-lead Holter monitor (2010 Plus
Philips Healthcare, Eindhoven, The Netherlands). For the current analyses, time and
frequency domain HRV parameters were characterized, during a 10 min rest period at our
clinical facility, performed in the sitting position, immediately prior to the collection of the
other biomarker endpoints at each sampling time point. All normal-to-normal intervals from
the 10-min recording windows were analyzed for time and frequency domain parameters in
10-min epochs using standard, validated algorithms on Zymed analysis software. The
software automatically detected heart beats and labeled ectopic beats such as periventricular
contractions or pretrial contractions. A trained technician working with an Emory
cardiologist then visually viewed the ECG tracing, removing regions with noise, artifact and
ectopy. Time domain parameters included the standard deviation of all normal to-normal
intervals (SDNNs) and the square root of the mean squared difference between adjacent
normal-to-normal intervals (rMSSDs); frequency domain parameters included power in the
high frequency range (HF), power in the low frequency range (LF) and the LF/HF ratio.
Average heart rate was also reported. Systemic inflammation (sICAM-1, sVCAM1,
IL-1β,IL-6IL-8 and TNF-α were analyzed in plasma, using Vascular Injury Panel II assay,
Human Proinflammatory II 4-plex assay ultra-sensitive kit (Meso Scale Discovery,
Gaithersburg, MD).
Subjects were asked to complete a diary card to record the baseline incidence of respiratoryrelated symptoms, diets, time spent in traffic and exposures to other pollutant generating
activities. Finally, subject stress levels were assessed by examining salivary cortisol
concentrations, both before and immediately after the commute via ELISA analytical
methods (ENZO life sciences Farmingdale, NY, USA).

Author Manuscript

2.3. Pollutant measurements
A range of size- and chemically-resolved particulate components were measured in each
vehicle from filter samples collected during the 2-h scripted commutes using both
continuous and time-integrated instrumentation. Inlets for all the instruments were situated
in the passenger side of the front seat, no more than 1 m from the breathing zone of the
driver with pump exhaust routed to the exterior of a rear window. We measured PM2.5 mass
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(AeroTrak model 9306 (TSI Inc., Shoreview, MN); particle number concentration (PNC)
(CPC model 3007 (TSI Inc., Shoreview, MN); black carbon concentration (BC)(MicroAeth
AE51 (AethLabs, San Francisco, CA); and particle-bound polycyclic aromatic hydrocarbons
(pb PAH) (PAS 2000CE (EcoChem Analytics, League City, TX) continuously during the
commute periods. Filter-based analyses were performed at Emory University, Georgia Tech,
and the University of Wisconsin. For these analyses, we present results for a subset of
pollutants which were selected, a priori, to reflect specific traffic sources or physiochemical
categories. For the carbonaceous species, we included total organic carbon (OC), total
elemental carbon (EC), water soluble organic carbon (WSOC), total pb-PAHs, n-alkanes,
and total hopanes as markers of various internal combustion engine processes. For the
elemental species, we included transition metal species (zinc, copper, nickel, vanadium,
iron, manganese, chromium, and aluminum), as well as specific tracers of on-road source
categories, including lead, antimony and sulfur. All of these chemical components were
measureable, above their respective detection limits, in greater than 79% of the collected
filter samples. In addition, in-cabin noise levels were measured continuously during the
commutes using a noise decibel meter (Extech HD600, Extech Instruments, Nashua, NH).
Noise has previously been suggested as a potential confounder of traffic-related health
effects in epidemiologic studies of air pollution (Babisch, 2005; Boogaard et al., 2009). All
collected data were assessed for bias, precision and completeness. Full details on the data
quality parameters for all of the measured pollutants can be found elsewhere (Greenwald et
al. 2014).
2.4. Epidemiologic analyses

Author Manuscript

Associations between exposures and response were examined using mixed-effects linear
regression analyses. All endpoints were transformed logarithmically given non-normality in
their respective distributions. We used two, complementary mixed-effects modeling
approaches to examine biological changes associated with the commuting periods. First,
time trends in the specific endpoints at pre- and various post-commute periods were
examined as:

(1)

Author Manuscript

where Yijk was the endpoint measurement for subject i at time j (with time1–time4 being
indicator variables for the baseline measurement, and measurements 0, 1, 2 and 3 h after the
commute) on commutek (1 or 2). This model included a random intercept for subject (b0i),
and a spatial power covariance structure for the error term (εijk) allowing for additional
correlation between biomarker values at different times for the same subject (in SAS Proc
Mixed, type sp(pow)(c-list)). The coefficients (β's) for the various time points after the
commute can interpreted as the extent to which the log of the outcome changed at time
j=1,2,3, or 4 relative to time 0 (j=0). The effects were expressed as the average percent
change relative to baseline with the percent change calculated as (exp(βj)–1) × 100. It should
be emphasized that this time trend model, which we refer to as the ‘commute as exposure’
models, may reflect changes due to one or multiple factors experienced during the commute,
chemical or non-chemical, or even natural diurnal patterns.
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We also examined the relationship between measured in-vehicle pollution and
corresponding changes in the biomarker measurements between the baseline time point and
post-commute time points. For these models, the outcome was the difference in log
transformed in values between the baseline and post-commute time points. The models had
the following form:
(2)

Author Manuscript

where Δln(Yijk) is the difference between the natural log of the biomarker measurement for
subject i on commute k (1 or 2) at timej (j=1,2,3 or 4 representing 0, 1, 2 and 3 h after the
commute) and the natural log of the biomarker measurement for subject i on commutek
before the commute; and pollutionik is a measure of the level of a given pollutant during the
commute. We scaled effects associated with an approximate interquartile range (IQR)
increase in concentration for the various pollutant metrics. The model included a random
intercept for subject (b0i). The model also controlled for the natural log of the baseline
biomarker level for subject i on commutek (baseline lnY). A separate model was run for each
post-commute time point j.
Effect modification by asthma status (yes vs. no) and season (cold vs. warm, with cold
season defined as October 15–April 15) was assessed using stratified models and product
terms with the relevant exposure variables. As a sensitivity analysis, we included cortisol
concentrations, a marker of psychosocial stress, and in-vehicle noise as covariates in Eq. (2),
to assess the potential confounding of pollutant effects by these factors. All statistical
analyses were conducted using SAS v9.3 (SAS Institute Inc., Cary, NC).

Author Manuscript

3. Results
In total, 42 subjects conducted 81 highway commutes as part of the ACE-1 study.
Participant median age was 32 years (range: 20–58 years); 50% were women. Participants
with asthma had higher baseline eNO and lower baseline FEV1 compared to participants
without asthma (Table 1). Among the participants with asthma, half reported using asthma
medications regularly and six were considered ‘poorly controlled”. Commutes were
conducted during all seasons of the year and in all meteorological conditions. The majority
of commutes were conducted in sedans or hatchbacks (52/81 or 64%), followed by SUVs
(22 commutes), pickups (3), minivans (2), and station wagons (2). The median age of the
vehicles was 5 years with a range of < 1–16 years.

Author Manuscript

Characteristics of in-vehicle pollutant concentrations are shown in Table 2. In-vehicle
concentrations of BC, PNC, PM2.5 and pb-PAHs were generally elevated during the
commuting periods, relative to corresponding ambient pollutant concentrations (Greenwald
et al. 2014). Mean concentrations for these pollutants were typically higher during the
commutes for the non-asthmatic compared to the asthmatic participants (p < 0.05 for all)
(data not shown). Strong in-vehicle correlations existed between both the BC and EC and
corresponding pb-PAH concentrations (Spearman's r > 0.76), with weak to moderate
correlations among the other the measured pollutant distributions (Table 3). Detailed

Environ Res. Author manuscript; available in PMC 2016 March 25.

Sarnat et al.

Page 8

Author Manuscript

descriptive findings for the ACE-1 exposure measurements are detailed elsewhere
(Greenwald et al. 2014).
3.1. Time trends in measure biological endpoints: Commute as exposure models

Author Manuscript

3.1.1. Respiratory endpoints—eNO levels measured after commuting were from 8.3 to
13.7% higher than baseline levels (p < 0.001) at all post-commute time periods (Table 4,
Fig. 1). Peak eNO levels were measured at 1 h post commute, yet remained significantly
elevated relative to baseline levels at all post commute measurement periods. For both
asthmatic and non-asthmatic subjects, eNO levels exhibited modest declines at the final
follow-up time point, 3h after the subjects’ commutes (Fig. 1). MDA concentrations in
exhaled breath were higher than baseline levels in both asthmatic and non-asthmatic
subjects, albeit insignificantly, at the 0 h post-commute measurement time point (p=0.34)
and lower than baseline levels at the three subsequent measurement time points. FEV1 levels
were slightly elevated relative to baseline levels among asthmatic subjects at the 1 h and 2 h
post-commute time points (Table 4, Fig. 1). For all of the commute as exposure models, we
observed no significant difference in strength of response by asthma/non-asthma health
status.

Author Manuscript

3.1.2. Cardiovascular and other systemic endpoints—Slight elevations in CRP,
corresponding to levels that were approximately 8% higher than those measured before the
commute, were observed in the subjects at the 0 h post-commute time point (p=0.05)(Table
4, Fig. 1). This result was primarily driven by CRP response in the non-asthmatic subjects
(11.2% post-commute CRP increase; p=0.06). CRP levels remained elevated relative to
baseline levels for non-asthmatic subjects at 1 and 2 h post-commute, although none of these
estimates were statistically significant. Time trends in sICAM, sVCAM, IL-1Β, IL-6, IL-8,
and TNF-α concentrations, measured only at the baseline and 3 h post-commute time points,
were consistent with the null, in both asthmatic and non-asthmatic subjects (data not shown).

Author Manuscript

SDNN values were significantly lower at each of the post-commute measurement time
points (Table 4), with the lowest levels measured at the 0 h post-commute time point
(−31.2.4% change, p < 0.0001). For rMSSD in all subjects and SDNN in non-asthmatic
subjects, levels were closer to baseline levels 1 h after the commutes, roughly corresponding
to 10 AM for most subjects, which remained consistent until the end of the measurement
protocol around noon (Fig. 1). We conducted sensitivity analyses examining model
robustness associated with three extreme observations for SDNN. Results from models
removing these observations did not change the overall direction or interpretation for the
SDNN trend. At the 0 h post-commute time point, rMSSD levels were significantly lower
than baseline (change in post-commute rMSSD: −21.6%; p < 0.0006), although this finding
was largely driven by response in the asthmatic subjects. Model results examining changes
in the frequency domain HRV parameters, including High Frequency (HF), Low Frequency
(LF) and the ratio of the two measures, were all consistent with the null (data not shown).
A formal examination of interaction by health status showed significantly stronger
decrements in the asthmatic compared with the non-asthmatic subjects in both SDNN at the
0 h post-commute time-point (−47 vs. −26% for the asthmatic and non-asthmatic subjects,
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respectively, interaction: p=0.027) and rMSSD at the 0 h post-commute time-point (−43 vs.
−2% for the asthmatic and non-asthmatic subjects, p=0.003). No other significant
differences were detected between these two cohorts among all of the endpoints we
examined. There was no observed effect measure modification by season (results not
presented).
3.2. In-vehicle pollution as a predictor of response

Author Manuscript

Results from analyses using the in-vehicle pollutant concentrations as predictors of changes
in the biomarker endpoints were highly variable, and largely consistent with the null. Of the
pollutant models we considered, the clearest and most consistent positive associations
existed between WSOC and changes in eNO relative to baseline at all post-commute time
points (p < 0.05 during 0, 1, 2, and 3 h post commute) (Fig. 2). There were also positive
associations between in-vehicle PM2.5 mass and Fe levels and changes in eNO at the 0 h
time point (Fig. 2). WSOC, PM2.5 mass and Fe were all negatively associated with MDA at
the 2 h post-commute time period. Associations between changes in eNO and WSOC and Fe
levels remained significant during both seasons, with positive associations between BC and
pb-PAHs and eNO in the cool season alone (p < 0.0009 for both, results not shown). All
pollutant associations were robust to the inclusion of in-vehicle noise and cortisol levels as
covariates in the models. Neither noise nor cortisol levels were independently associated
with any of the measured endpoints.

4. Discussion

Author Manuscript

We conducted the ACE-1 study to examine whether car commuting during morning rush
hour conditions is associated with acute, sub-clinical changes in markers of oxidative stress
and inflammation. During the commutes, we measured substantially elevated in-vehicle
particulate pollutant concentrations relative to ambient concentrations (Greenwald et al.
2014). At measurement time points within 3 h after the commute, we observed mild to
pronounced elevations in eNO, CRP, and MDA relative to baseline in these subjects,
indicative of pulmonary and systemic inflammation and oxidative stress initiation, as well as
decreases relative to baseline levels in the time-domain HRV parameters, SDNN and
rMSSD, indicative of autonomic dysfunction. For several of these endpoints, including eNO
and SDNN, response occurred in subjects both with and without asthma. Further, several
biomarkers exhibited trends indicating a return to approximate baseline levels within a 3 h
follow up period. Since the participants were non-randomly selected volunteers, these results
may not be general-izable to individuals outside of this panel.

Author Manuscript

Among the pulmonary response endpoints, the most pronounced effects were seen in eNO,
which we hypothesized as potentially most temporally sensitive to air pollution insult. Peak
eNO levels were observed at 1 h post-commute and exhibited modest declines at the final
follow-up period, 3 h after the subjects’ commutes. Given the relatively short follow-up
period for this study, however, inferences relating to the temporality of any of the endpoints
should be viewed cautiously. Numerous studies have reported associations between air
pollution and acute eNO response utilizing panel based designs (Adamkiewicz et al., 2004;
Buonanno et al., 2013; Delfino et al., 2006; Greenwald et al., 2013; Sarnat et al., 2012).

Environ Res. Author manuscript; available in PMC 2016 March 25.

Sarnat et al.

Page 10

Author Manuscript
Author Manuscript

Notably, the elevated eNO response was similar in subjects both with and without asthma,
with slightly stronger associations existing for the subjects with asthma. As expected,
baseline eNO levels were higher in asthmatic subjects (Table 1), so percent increases from
baseline levels also denote larger absolute increases in measured eNO concentrations. We
did not expect a response of this magnitude in the non-asthmatic subjects. There is limited
information concerning the use of eNO as a biomarker of acute pulmonary inflammation in
individuals without preexisting respiratory disease (Alving and Malinovschi, 2010). In both
asthmatic and non-asthmatic subjects, eNO is produced in the upper and peripheral airways
and alveoli by the expression of inducible nitric oxide synthase (iNOS) in epithelial cells
(Alving and Malinovschi, 2010; Barnes and Kharitonov, 1996). Regulation of iNOS is
influenced by the cytokines IL-4 and IL-13 on a pathway involving the transcription factors
STAT-6 and AP-1 which in turn are responsive to airway oxidative status (Alving and
Malinovschi, 2010). The results presented here are consistent with this model of eNO
production; namely, that highway commuters are exposed to inhaled oxidants, which alter
redox balance after rapid dissolution in the airway epithelium. This may lead to upregulation
of systemic cytokines and increased expression of iNOS in both non-asthmatic and
asthmatic subjects. The expression of iNOS is elevated in the bronchial epithelium of
asthmatics leading to higher baseline eNO, which may also result in a higher absolute
change in eNO. While biologically plausible, the eNO trends may also indicate exposures to
stress in the subjects. A recent clinical study showed eNO in asthmatic and non-asthmatics
to be associated with psychological stress, also expressed as changes in the subjects’
salivary cortisol levels (Ritz et al., 2011). While cortisol was not independently predictive of
any of the current health responses, at the very least, the role of psychosocial stress as an
additional biologically-plausible driver of respiratory response should be considered.
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MDA levels in EBC were slightly, albeit insignificantly, elevated in both asthmatic and nonasthmatic subjects at the measurement period immediately following the commutes (8.6%
increase relative to baseline levels), and were not elevated relative to baseline during later
measurement periods. While statistically insignificant, the trends are suggestive of acute
oxidative stress and inflamma-tory processes occurring in the lung. This interpretation is
supported by our eNO findings as well as similar results from a recent natural intervention
study showing lagged associations between MDA in exhaled breath and several ubiquitous
urban air pollutants, at lags of 1–4 days, in a panel of 125 healthy adults living in Beijing
during the 2008 Olympics (Gong et al., 2013). While methods for measuring EBC
biomarkers of oxidative stress and associated processes are still novel (Effros et al., 2004;
Horvath et al., 2005), the ability to characterize these processes in exhaled breath is
important for elucidating mechanistic pathways of air pollution toxicity.

Author Manuscript

We did not see anticipated decrements in either FEV1 or FVC at the post commute
measurement time points, as has been reported in a previous panel study examining
exposures in a heavy traffic emission environments (McCreanor et al., 2007). The current
results showing FEV1, specifically, to be slightly and significantly elevated at the postcommute time points may be an artifact of our repeated measure design, and improved
subject performance, over time, in completing the spirometry protocol. Among the nonrespiratory endpoints we analyzed, CRP was slightly elevated in the 0 h post commute
measurement period only. Previous panel studies have shown similar increases in CRP
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following exposures to traffic pollution at longer time lags (~hours-to-days) (Brook et al.,
2010; Chuang et al., 2007; Riediker et al., 2004), presumably reflecting a lengthy cascade of
inflammation-mediated steps in its production (Ruckerl et al., 2006). It is conceivable,
however, that a more rapid acute phase response in CRP, similar in magnitude to that
reported here, can occur following insult (Ghio et al., 2003; Pepys and Hirschfield, 2003;
Seo, 2012). Admittedly, the lack of measureable post-commute elevations in the other
vascular inflammation biomarkers, including some known to be precursors of CRP
production (i.e., IL-6); in addition to apparent complete clearance of CRP at the 1 h postcommute time point, for a protein with a reported plasma half-life of 8–18 h (Pepys and
Hirschfield, 2003), complicates the interpretation of these results. Overall, we view these
CRP findings as intriguing and supportive of future investigation.

Author Manuscript
Author Manuscript

SDNN in all subjects and rMSSD in the asthmatic subjects, exhibited marked post-commute
changes, mainly at the measurement period immediately following the commutes. Among
the time- and frequency-domain HRV metrics we measured, these were the only two for
which responses were observed. Reviews examining the link between short-term exposures
to air pollution and HRV note the variability of results (Brook et al., 2010), with studies
reporting decreases in primarily the frequency-domain HRV parameters (Adar et al., 2007;
Laumbach et al., 2010; Riediker et al., 2004; Shields et al., 2013), and decreases in timedomain HRV parameters, similar to the current results (Liao et al., 1999; Shields et al.,
2013). In a panel study examining traffic pollution, Shields et al (2013) recently found
associations between traffic-related PM exposures and acute reductions in HRV in a middleaged Mexico City population. A recent study of 21 subjects with type-2 diabetes also found
reductions in HF mainly one day after subjects completed 90- to 110-min car rides on a busy
highway (Laumbach et al., 2010). Similarly, Adar et al (2007) reported reductions in
frequency-domain HRV associated with in-vehicle pollutant exposures in 44 non-smoking
senior adults during highway commutes on a diesel-powered mini-bus (Adar et al., 2007).
The stronger SDNN and rMSSD response that we observed in the asthmatic subjects is
intriguing. While speculative, the observed discrepancy in autonomic response may reflect
enhanced underlying sensitivity to inflammation-mediated processes in asthmatic subjects
which, in turn may trigger reduced vagal function (Rhoden et al., 2005; Simkhovich et al.,
2008).

Author Manuscript

We cannot rule out the explanation that the SDNN results, in particular, reflect diurnal
patterns in autonomic function, mediated via circadian rhythmicity or other endogenous
mechanisms (Vandewalle et al., 2007), rather than the effect of external stressors
experienced during the commute itself. Interestingly, most of the subjects exhibited some
degree of post-commute decline in SDNN, with only 10 of 60 observations (17%) showing
mean SDNN readings higher at the post-commute period compared to baseline
measurements. Although limited information exists regarding HRV diurnal patterns, it has
been suggested that SDNN substantially decreases after waking and may exhibit modest
elevations during the late morning or early afternoon (Burger et al., 1999; Vandewalle et al.,
2007), which is roughly consistent with the trends we observed in the ACE-1 subjects.
An important limitation of this quasi-experimental design was the lack of a comparison
commute with substantially lower exposure levels; this would have afforded time trend
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comparisons between commutes with larger differences in exposure, such as “exposed” vs.
“non-exposed” conditions. Barring this element of control, we cannot preclude an
explanation that normal diurnal variability, in any of the measured biomarkers, is truly
responsible for the observed time-trend model results (Eq. (1)). It is improbable that the
time-trend results, which reflect changes in multiple endpoints, processes and biological
systems, are solely expressions of normal diurnal patterns. Moreover, indications of an acute
return to baseline levels for many of the endpoints shortly after the commutes, argue against
this interpretation. Similar to other on-road exposure study designs (Adar et al., 2007;
Riediker et al., 2004), the strategy for designing the ACE-1 study to include two highway
commutes was intentional and, and intended as a means of enhancing intra-individual
variability in exposure and improving our ability to detect changes in response associated
with different within-commute levels of specific pollutant components (using the analyses
described by Eq. (2)). We note that the recently completed ACE-2 panel study follows an
additional 60 subjects during both a highway commute, similar to ACE-1, as well as a
control, non-highway traffic exposure session for all participants. This second study will
provide opportunities to directly examine the presence of biomarker diurnality and the
potential that other forms of confounding are responsible for the observed time trend results.

Author Manuscript
Author Manuscript

By design, the models examining changes in response as a function of in-vehicle pollution
(Eq. (2)) are not subject to this form of potential temporal confounding, since diurnal
variability in the endpoints should not be correlated with the in-vehicle pollutant
measurements. Results from models including individual pollutants or classes of pollutants
(e.g., pb-PAH's, transition metal species) as predictors of response were largely consistent
with the null, with the exception of a few notable associations. In this study, in-vehicle
WSOC and, to a lesser degree PM2.5 and Fe, were predictors of corresponding changes in
eNO. The WSOC finding agrees with previous results from a panel study of 60 older adults
with coronary artery disease, in which eNO was also associated with WSOC, as well as
organic acids (Delfino et al., 2010). In that study conducted in Los Angeles, WSOC was
attributed to photo-chemically-produced, secondary organic aerosol in the ultrafine particle
range. The origin of the WSOC we measured, either biogenic or anthropogenic, primary or
secondary, is not known. Although speculative, it is worth noting that the strong eNOWSOC associations existed in both warm and cool seasons, perhaps indicating a
contribution from non-photochemically produced components of WSOC. We did not find
any indication that in-vehicle noise or cortisol levels, a marker of psychosocial stress, either
confounded these observed pollutant effects or were independent predictors of any
biomarker variability. Future analyses examining alternative ways of characterizing
biologically relevant noise and stress metrics may provide additional information about the
potential role of these commuting-related exposures.
The general lack of observed associations from the pollutant models may be due to several
factors, including errors associated with analytical imprecision and uncertainty stemming
from the measurement of trace pollutant species at their limits of detection. It is also
possible that the extensive suite of particulate pollutants we measured was not causally
associated with the selected endpoints, or at least not associated with measureable response
within this acute timeframe. Further, unmeasured gaseous or non-chemical environmental
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factors (Zappulla, 2008), which are also present during commuting, may be the true drivers
of biomarker variability.

Author Manuscript

Clearly, the in-vehicle microenvironment is a highly dynamic exposure setting. During their
participation in this study protocol, subjects were exposed to multiple exogenous and
endogenous stressors that can elicit similar physiological response via numerous oxidative
stress and inflammation pathways. While commuting, individuals may be cumulatively
exposed to elevated particulate and gaseous chemical pollution, noise, and psychosocial
stress. It is possible, and perhaps probable, that these stressors, as well as elements of the
commuting protocol itself, contribute a t varying degrees to the biological responses we
observed in this panel. Traditional health effects modeling involving single pollutants or
even pollutant categories (e.g., total PAHs), thus, may be inadequate for capturing
variability attributable to this rich mixture of stressors. This challenge necessitates the
development of novel exposure metrics that better reflect the multiplicity of exposures
occurring during typical commuting. For this type of setting, it is possible that our ‘commute
as exposure’ models (in which we did observe clear differences in our outcome measures
after the commute compared with baseline) best represents the biologically-relevant mix of
exposures one typically experiences during commuting.

Author Manuscript

In spite of these areas of uncertainty, we believe that these results collectively point to
measureable changes in pulmonary, autonomic and other systemic biomarkers following the
scripted 2 h highway driving protocol. A thorough characterization of in-vehicle PM
exposure and acute health response represents a key environmental health challenge given
that the duration of the average commute to work in the United States has increased steadily
in recent decades to a national average of 25.5 min. The U. S. Census Bureau reports that
over 8.1% of Americans spend at least an hour each day commuting to and from their place
of work with almost 600,000 people commuting at least three hours per day (U. S. Census
Bureau report March 2013).
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Fig. 1.

Percent change, over time, in selected health endpoints for the entire panel (left), subjects
without asthma (center), and subjects with asthma (right). Abbreviations: eNO exhaled nitric
oxide; FEV1 forced expiratory volume in 1 s; MDA malondialdehyde; SDNN standard
deviation of normal-to-normal intervals; RMSSD square root of the mean squared difference
between adjacent normal-to-normal intervals; CRP C-reactive protein.
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Fig. 2.

Percent change in biomarker per change in selected pollutant. Coefficient scaling for PM2.5:
per 10 μ/m3; EC: per 1 μg/m3; WSOC: 2 μg/m3; Fe: 250 ng/m3. Abbreviations: PM2.5=fine
particulate matter; EC=elemental carbon; WSOC=water soluble organic carbon; Fe=iron.
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Baseline characteristics of study population by health status.
a

Characteristics

All participants (N=42)

Subjects with
asthma (N=21)

Subjects w/o asthma
(N=21)

Number of commutes

81

41

40

Female (%)

50

62

38

0.12

Age, years [median (range)]

32.4 (20-58)

29.9 (20-58)

35.0 (22-57)

0.20

b
Caucasian (%)

61.9

61.9

57.1

0.75

BMI (kg/m2) (mean ± SD)

23.5 (3.6)

22.8 (2.1)

24.4 (4.6)

0.42

Treatment with inhaled corticosteroids n (%)

6 (28.6)

-

Treatment with beta-agonist n (%)

12 (57.1)

-

24 (9-174)

28 (10-174)

18 (9-104)

0.02

0.097 ± 0.06

0.10 ± 0.6

0.09 ± 0.05

0.4

    FVC

96.4 ± 14.1

95.3 ± 11.3

97.4 ± 16.5

0.52

    FEV1

94.8 ± 15.6

91.4 ± 14.2

98.3 ± 16.3

0.05

    Systolic blood pressure (mmHg)

115.1 ± 14.5

114.8 ± 15.0

115.7 ± 14.3

0.82

    Diastolic blood pressure (mmHg)

78.4 ± 9.3

75.9 ± 8.6

81.1 ± 9.5

0.04

Heart rate (bpm)

77.3 ± 16.3

76.7 ± 16.5

78.1 ± 16.6

0.75

    SDNN “10 min” (mm2)

94.1 ± 32.4

85.5 ± 34.0

85.5 ± 34.0

0.36

    RMSSD “10 min” (mm2)

61.5 ± 36.6

71.7 ± 39.8

50.2 ± 29.6

0.45

    HF LF ratio “10 min”

1.03 ± 0.5

1.2 ± 0.6

0.9 ± 0.2

0.13

    C-reactive protein, (mg/L)

1.72 ± 2.0

1.57 ± 1.6

1.86 ± 2.4

0.6

    Soluble Intercellular adhesion molecule 1(ng/mL)

1804 ± 1445

1021 ± 1361

2544 ± 1100

< 0.0001

    Soluble vascular cell adhesion molecule-1(ng/mL)

2928 ± 2314

1624 ± 1917

4162 ± 1917

< 0.0001

    Interleukin 1-beta (pg/mL)

0.31 ± 0.4

0.41 ± 0.5

0.23 ± 0.2

0.07

    Interleukin 6 (pg/mL)

0.93 ± 0.5

0.77 ± 0.4

1.1 ± 0.6

0.015

    Interleukin 8 (pg/mL)

6.1 ± 6.7

8.45 ± 8.8

3.89 ± 2.1

0.005

Other endpoints

2.4 ± 1.0

3.05 ± 1.0

1.85 ± 0.5

< 0.0001

p Value

Respiratory endpoints
    eNO, ppb [median (range)]

Author Manuscript

    Malondialdehyde (MDA) μM (mean ± SD)
Lung function % of predicted value (mean ± SD)

c

Cardiovascular endpoints (mean ± SD)
Blood pressure

Heart rate variability

Author Manuscript

Inflammation biomarkers [mean (SD)]

    Salivary cortisol pg/mL [mean (SD)]

Author Manuscript

Abbreviations: BMI body mass index; eNO exhaled nitric oxide; FVC Forced vital capacity; FEV1 Forced expiratory volume in 1 s; SDNN
standard deviation of normal-to-normal intervals; RMSSD square root of the mean squared difference between adjacent normal-to-normal
intervals.
a

p-Values for t-tests for continuous variables and chi-square tests (when all cell values > 5) or Fisher's exact test for categorical variables.

b

Race was self-reported.

c
Metrics of lung function are reported as percent of age-, sex-, and race-specific predicted values (Hankinson et al., 1999).
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Descriptive statistics for in-vehicle PM2.5 concentrations, PNC, and concentrations of organic components and
transition metals from 2-h commutes.
Pollutant

n Commutes

Mean

SD

Median

Min/max

72

19.2

13.6

15.2

3.08/85.5

76

26,067

12,211

24,218

78

6.6

3.3

6.00

1/16

a
Element carbon (μg/m3)

76

2.8

1.8

2.3

0.34/8.3

a
Organic carbon (μg/m3)

75

19.2

6.9

18.6

6.04/38.4

WSOC (μg/m3)

72

6.2

3.9

5.5

0.4/26.7

pb-PAHs (ng/m3)

78

118.8

32.3

116

50/207

(pg/m3)

72

822.3

631.0

642.3

67.59/4,218

75

54996

143,840

32,598

3062/1257,613

69

71.6

3.6

72.0

62.2/81.9

V

76

0.6

0.8

0.4

0.012/7.1

Cr

66

1.3

1.3

0.9

0.008/7.3

Mn

76

2.4

2.2

1.7

0.008/12.0

Fe

75

247.4

232.3

193.4

0.52/1358

Ni

66

1.5

3.1

0.6

0.056/23.1

Cu

73

39.8

57.0

20.7

0.094/3255

Zn

74

19.4

30.1

8.2

0.14/170

Al

71

39.1

46.5

23.5

0.41/265

S

74

381.6

488.1

252.5

17.50/2784

Sb

72

2.9

2.8

2.2

0.023/17.1

Pb

76

1.7

2.8

0.8

0.02/16.7

PM2.5 mass

(mg/m3)

Particle number
Black carbon

Hopanes

Author Manuscript

n-Alkanes

(n/cm3)

(μg/m3)

(pg/m3)

Noise (dB)
Elements

4,936/68,951

(ng/m3)

Author Manuscript

Abbreviations:PM2.5 Particle matter 2.5; WSOC water soluble organic carbon; pb-PAHs particle-bound polycyclic aromatic hydrocarbons;
Alkanes C23 to C27 = sum of n-alkanes with 23-27 carbons. V Vanadium; Cr Chromium; Mn Manganese; Fe Iron; Ni Nickel; Cu Copper; Zn
Zinc; Al Aluminum; S Sulfur Sb Antimony Pb Lead; Max, maximum; Min, minimum.
a

Measured using filter-based thermal-optical transmittance.

Author Manuscript
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Table 3

Author Manuscript

Pearson correlation coefficient matrix among select in-vehicle particulate components.
Pollutant

PNC

PM2.5 mass

0.36

PNC
BC
EC
OC
WSOC
Pb-PAHs

*

BC

EC

*

0.50

*

0.25

*

0.39

*

0.26

*

0.65

OC

WSOC
*

0.01

*

–0.01

0.43
0.29
0.21

–0.11
*

0.53

–0.09
–0.04

Pb-PAHs
*

0.44

*

0.31

*

0.85

*

0.76

*

0.30

–0.14

Hopanes

n-Alkanes

Noise

*

0.04

0.27

*

0.06

0.27

*

–0.08

–0.005

*

–0.03

0.11

*

0.05

0.36

*

0.08

–0.07

0.03

0.13

0.22

0.37
0.34
0.33
0.36
0.35

*

0.32

*

0.46

Hopanes

0.25

Author Manuscript

0.07

n-Alkanes

Abbreviations:PM2.5 Particle matter 2.5; BC black carbon; OC organic carbon; WSOC water soluble organic carbon; pb-PAHs particle-bound
polycyclic aromatic hydrocarbons n-Alkanes = sum of n-alkanes with 23-27 carbons.
*

p < 0.05.

Author Manuscript
Author Manuscript
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Table 4

Author Manuscript

Association between commute and biomarker changes, linear mixed model (N = 80).
Parameter estimate

SE

df

t Value

p Value

Percent change

8.8

1.8

327

4.84

< 0.0001

9.2

    Non-asthmatics

9.6

2.5

159

3.85

0.0002

10.1

    Asthmatics

8.0

2.6

163

3.04

0.002

8.3

11.7

2.2

327

5.36

< 0.0001

12.4

10.6

3.0

159

3.51

0.0006

11.1

12.9

3.1

163

4.10

< 0.0001

13.7

11.3

2.5

327

4.55

< 0.0001

11.9

    Non-asthmatics

10.2

3.4

159

2.98

0.003

10.7

    Asthmatics

12.4

3.5

163

3.48

0.0006

13.2

eNO
Post commute

1 h post commute

All

All

    Non-asthmatics
    Asthmatics
2 h post commute

Author Manuscript

3 h post commute

All

9.9

2.7

327

3.62

0.0003

10.4

    Non-asthmatics

All

8.2

3.8

159

2.18

0.03

8.5

    Asthmatics

11.6

3.9

163

2.96

0.003

12.3

0.7

0.5

328

1.35

0.18

0.7

0.3

0.6

157

0.40

0.69

0.2

1.1

0.8

166

1.43

0.15

1.1

1.9

0.6

328

3.09

0.002

1.9

    Non-asthmatics

0.9

0.8

157

1.22

0.22

1.0

    Asthmatics

2.9

0.9

166

3.03

0.003

2.9

1.6

0.7

328

2.26

0.02

1.6

1.0

0. 9

157

1.02

0.31

0.9

2.3

1.0

166

2.13

0.03

2.3

1.5

0.8

328

1.91

0.06

1.5

    Non-asthmatics

1.3

0.9

157

1.31

0.19

1.3

    Asthmatics

1.7

1.2

166

1.44

0.15

1.7

–0.2

0.4

323

–0.36

0.72

–0.16

    Non-asthmatics

–0.04

0.6

157

–0.08

0.94

–0.04

    Asthmatics

–0.3

0.6

161

–0.42

0.67

–0.27

FEV1
Post commute

All

    Non-asthmatics
    Asthmatics
1 h post commute

2 h post commute

All

All

    Non-asthmatics

Author Manuscript

    Asthmatics
3 h post commute

all

FVC
Post commute

1 h post commute

All

Author Manuscript

0.5

0.5

323

0.98

0.33

0.5

    Non-asthmatics

0.2

0.7

157

0.30

0.76

0.2

    Asthmatics

0.8

0.8

161

1.08

0.28

0.8

2 hour post commute all

0.3

0.6

323

0.45

0.65

0.3

    Non-asthmatics

–0.1

0.8

157

–0.17

0.87

–0.14

    Asthmatics

0.7

0.9

161

0.79

0.43

0.7

3 h post commute

all

0.4

0.

323

0.66

0.51

0.4

    Non-asthmatics

all

0.3

0.9

157

0.33

0.74

0.3

    Asthmatics

0.6

0.9

161

0.61

0.54

0.6
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Parameter estimate

SE

df

t Value

p Value

Percent change

8.6

8.9

285

0.96

0.34

8.9

    Non-asthmatics

7.1

11.8

125

0.60

0.55

7.3

    Asthmatics

10.0

13.0

155

0.77

0.44

10.5

–10.1

9.1

285

–1.11

0.27

–9.6

–8.7

12.5

125

–0.70

0.48

–8.4

–12.0

13.1

155

–0.91

0.36

–11.3

–14.4

9.1

285

–1.58

0.11

–13.4

    Non-asthmatics

–10.6

12.3

125

–0.86

0.39

–10.0

    Asthmatics

–17.8

13.2

155

–1.35

0.18

–13.6

MDA

Author Manuscript

Post commute

1 h post commute

All

All

    Non-asthmatics
    Asthmatics
2 h post commute

3 h post commute

All

–17.4

9.2

285

–1.90

0.06

–15.9

    Non-asthmatics

All

–17.5

12.5

125

–1.40

0.16

–16.0

    Asthmatics

–17.9

13.2

155

–1.36

0.18

–16.4

Author Manuscript

CRP
Post commute

All

    Non-asthmatics
    Asthmatics

8.0

4.1

201

1.96

0.05

8.3

10.6

5.6

103

1.89

0.06

11.2

5.6

5.6

93

1.00

0.32

5.7

–0.9

4.8

201

–0.19

0.85

–0.9

    Non-asthmatics

3.9

6.4

103

0.62

0.54

4.0

    Asthmatics

–5.6

6.5

93

–0.87

0.39

–5.5

0.6

5.4

201

0.12

0.91

0.6

5.9

6.9

103

0.85

0.40

6.0

–5.1

7.5

93

–0.68

0.50

–4.9

1.0

5.8

201

0.18

0.86

1.0

    Non-asthmatics

0.6

7.1

103

0.09

0.93

0.6

    Asthmatics

2.1

8.2

93

0.25

0.80

2.1

–6.0

3.5

236

–1.73

0.08

–5.8

1 h post commute

2 h post commute

All

All

    Non-asthmatics
    Asthmatics
3 h post commute

All

Author Manuscript

Heart rate
Post commute

All

    Non-asthmatics

1.1

4.7

103

0.24

0.81

1.1

–10.8

4.8

128

–2.24

0.03

–10.2

–0.1

3.5

236

–0.03

0.97

–0.1

2.9

4.9

103

0.59

0.56

2.9

–2.2

4.8

128

–0.45

0.65

–2.2

–3.1

3.6

236

–0.86

0.39

–3.0

    Non-asthmatics

–0.6

5.0

103

–0.12

0.91

–0.6

    Asthmatics

–4.8

5.1

128

–0.95

0.34

–4.7

    Asthmatics
1 h post commute

All

    Non-asthmatics
    Asthmatics
2 h post commute

3 h post commute

All

Author Manuscript

–0.9

3.6

236

–0.25

0.80

–0.9

    Non-asthmatics

All

–1.0

5.1

103

–0.19

0.85

–1.0

    Asthmatics

–0.7

5.0

128

–0.15

0.88

–0.7

–37.4

5.0

263

–7.54

< .0001

–31.2

–25.7

6.9

117

–3.72

0.0003

–22.6

SDNN10
Post commute
    Non-asthmatics

All
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Parameter estimate

SE

df

t Value

p Value

Percent change

–47.0

6.9

141

–6.86

< .0001

–37.5

–15.5

5.2

263

–2.99

0.003

–14.3

    Non-asthmatics

–4.8

7.3

117

–0.66

0.51

–4.7

    Asthmatics

–24.5

7.1

141

–3.47

0.0007

–21.7

–17.8

5.3

263

–3.35

0.0009

–16.3

–11.7

7.4

117

–1.57

0.12

–11.0

–22.9

7.2

141

–3.17

0.002

–20.5

–18.7

5.4

263

–3.46

0.0006

–17.0

    Non-asthmatics

–14.3

7.5

117

–1.90

0.0596

–13.3

    Asthmatics

–22.5

7.4

141

–3.05

0.003

–20.2

–24.3

7.0

262

–3.48

0.0006

–21.6

    Non-asthmatics

–1.8

9.2

116

–0.20

0.84

–1.8

    Asthmatics

–42.5

9.9

141

–4.29

< .0001

–34.6

–8.1

7.2

262

–1.12

0.27

–7.6

1.4

9.4

116

0.15

0.88

1.4

–15.9

10.3

141

–1.54

0.12

–14.7

–7.2

7.4

262

–0.98

0.33

–7.0

    Asthmatics

Author Manuscript

1 h post commute

2 h post commute

All

All

    Non-asthmatics
    Asthmatics
3 h post commute

All

rMSSD10
Post commute

Author Manuscript

1 h post commute

All

All

    Non-asthmatics
    Asthmatics
2 h post commute

All

    Non-asthmatics
    Asthmatics
3 h post commute
    Non-asthmatics
    Asthmatics

All

2.2

9.5

116

0.23

0.81

2.3

–15.1

10.5

141

–1.44

0.15

–14.0

–2.3

7.5

262

–0.30

0.76

–2.2

9.0

9.5

116

0.94

0.35

9.4

–11.7

10.8

141

–1.08

0.28

–11.0

Author Manuscript

Abbreviations: eNO exhaled nitric oxide; FVC forced vital capacity; FEV1 forced expiratory volume in 1 s; MDA malondialdehyde; CRP Creactive protein; SDNN standard deviation of normal-to-normal intervals; RMSSD square root of the mean squared difference between adjacent
normal-to-normal intervals.
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